. Angiotensin-induced defects in renal oxygenation: role of oxidative stress. Am J Physiol Heart Circ Physiol 288: H22-H28, 2005; doi:10.1152/ajpheart.00626.2004.-We tested the hypothesis that superoxide anion (O 2 Ϫ ⅐) generated in the kidney by prolonged angiotensin II (ANG II) reduces renal cortical PO 2 and the use of O 2 for tubular sodium transport (TNa:QO 2 ). Groups (n ϭ 8 -11) of rats received angiotensin II (ANG II, 200 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 sc) or vehicle for 2 wk with concurrent infusions of a permeant nitroxide SOD mimetic 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl (Tempol, 200 nmol ⅐ kg Ϫ1 ⅐ min Ϫ1 ) or vehicle. Rats were studied under anesthesia with measurements of renal oxygen usage and PO 2 in the cortex and tubules with a glass electrode. Compared with vehicle, ANG II increased mean arterial pressure (107 Ϯ 4 vs. 146 Ϯ 6 mmHg; P Ͻ 0.001), renal vascular resistance (42 Ϯ 3 vs. 65
protein; P Ͻ 0.05), mRNA and protein expression for p22 phox (2.1-and 1.8-fold respectively; P Ͻ 0.05) and reduced the mRNA for extracellular (EC)-SOD (Ϫ1.8 fold; P Ͻ 0.05). ANG II reduced the PO 2 in the proximal tubule (39 Ϯ 1 vs. 34 Ϯ 2 mmHg; P Ͻ 0.05) and throughout the cortex and reduced the T Na:QO 2 (17 Ϯ 1 vs. 9 Ϯ 2 mol/mol; P Ͻ 0.001). Tempol blunted or prevented all these effects of ANG II. The effects of prolonged ANG II to cause hypertension, renal vasoconstriction, renal cortical hypoxia, and reduced efficiency of O 2 usage for Na ϩ transport, activation of NADPH oxidase, increased expression of p22 phox , and reduced expression of EC-SOD can be ascribed to O 2 Ϫ ⅐ generation because they are prevented by an SOD mimetic. reactive oxygen species: superoxide dismutase; TEMPOL; nitroxides; NADPH oxidase; hypertension THE RENAL OXYGEN USAGE (Q O 2 ) normally increases above a basal value in close relation to the chemical work performed in net tubular sodium transport (T Na ). The ratio T Na :Q O 2 is a measure of the efficiency with which the kidney uses O 2 for chemical work. However, Laycock et al. (36) reported that inhibition of nitric oxide (NO) synthase (NOS) in the dog's kidney increases Q O 2 despite a reduction in T Na . Because NO competes with O 2 for cellular respiration in tissues (6), the heart (1, 15, 37, 39) , and renal tubules (2, 29) , NOS inhibition may stimulate cellular respiration and uncouple it from chemical energy consumption, thereby reducing the T Na :Q O 2 .
The kidney of the spontaneously hypertensive rat (SHR) (60) and the postclip kidney of the two-kidney, one-clip (2K,1C) Goldblatt rat model of renovascular hypertension (62) are sites of enhanced reactive oxygen species (ROS) and functional NO deficiency. These kidneys utilize O 2 inefficiently for sodium transport and are relatively hypoxic. The defects in oxygenation in the SHR kidney are corrected by blocking the angiotensin type 1 receptor (AT 1 -R) (61) , and in the 2K,1C model are corrected by the SOD mimetic 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl (Tempol). The present series were designed to test the hypothesis that prolonged infusion of angiotensin II (ANG II) generates superoxide anion (O 2 Ϫ ⅐) that causes defective renal oxygenation.
METHODS
Studies were approved by the Georgetown University Animal Care and Use Committee. Adult Wistar-Kyoto (WKY) rats (175-250 g) were supplied by Harlen Sprague Dawley (Madison, WI). They were maintained on a standard rat chow (Purina; St. Louis, MO; Na ϩ content 0.3 g/100 g) with free access to food and water until the day of the study.
Protocols. Four groups (n ϭ 8 -11) were studied after 12-13 days of subcutaneous infusions from two osmotic minipumps (Alzet). Group 1 received vehicle (Veh; 0.154 M NaCl; 0.2 ml) from each minipump. Group 2 received ANG II (200 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 , Sigma;) plus a vehicle. This "slow pressor" dose of ANG II produces reproducible hypertension over 2 wk accompanied by oxidative stress and increased renal expression of the p22 phox component of NADPH oxidase and decreased expression of extracellular superoxide dismutase (EC-SOD) (7, 46, 59 Animal preparation and clearance measurements. Rats were prepared for clearance and micropuncture as described (60, 64) . In brief, animals were anesthetized with thiobarbital (Inactin, 100 mg / kg ip; Research Biochemicals, Natick, MA). A catheter was placed in a jugular vein for fluid infusion and in a femoral artery for recording of mean arterial pressure (MAP). The animals breathed spontaneously via a tracheostomy. A catheter was placed into the bladder to collect urine. The left kidney was exposed by a flank incision, cleaned of connective tissue, and stabilized in a Lucite cup. It was bathed in 0.154 M NaCl equilibrated with air at 37°C. After surgery was completed, rats were infused with a solution of 0.154 M NaCl and 1% albumin at 1.5 ml/h to maintain euvolemia (64) . Studies were begun after 60 min. For clearance, [ 3 H]inulin (0.1 Ci/ml; ICN Biochemicals, Costa Mesa, CA) was added to the intravenous fluid infusion. Urine was obtained from the bladder, and, at the end of the clearance period, blood was sampled from the femoral artery and renal vein using a no. 23-gauge steel needle angled toward the kidney. The study period lasted 60 -90 min, during which a single renal clearance was undertaken.
Measurements of arterial, renal venous, intranephronal, and tissue PO 2. Blood (100 l) for PO2 was drawn from the femoral artery and renal vein, capped, and kept on ice for measurement of O2 in a blood gas analyzer (Instrumentation Laboratory Synthesis; Boston, MA). Studies for nephron and tissue PO2 utilized a custom-designed and validated ultramicro, coaxial, recessed-tip platinum-irridium glass microelectrode (3, 40, 54) . The outer tip (diameter was 3-5 m) was coated with O 2-permeable collodion. It was inserted into superficial tubules or the interstitium of the superficial outer cortex (OC) or was inserted blindly below the surface into the inner cortex (IC) to provide a real-time measure of PO 2 using an ultra high impedence picoammeter (pA6000, WPI, Sarasota, FL).
Measurements of kidney function and parameters of O 2 usage. The glomerular filtration rate (GFR) was calculated from the clearance of (4) . TNa was calculated from the difference between the filtered load of sodium (calculated from the product of GFR and plasma sodium concentration) and the renal sodium excretion (U NaV). QO 2 was calculated from the product of renal blood flow (RBF) and arterial-venous O2 difference. The measurements of renal venous O2 content were made in the renal vein after it had exited from the kidney distal to any shunt pathway for O 2 (54, 60) . The oxygen efficiency for Na ϩ transport was calculated from the ratio of TNa:QO 2 .
Renal cortex O 2 Ϫ ⅐ production. Superoxide was measured by lucigenin-enhanced chemiluminescence (59). Briefly, NADPH (100 M) was added to the supernatant from the renal cortex in a reaction containing lucigenin (5 M) and 50 l protein in the assay buffer just before reading (11, 38) . Chemiluminescence was determined over 20 min in a luminometer (Lumat LB 9501; Berthold, Pforzheim, Germany). Basal and NADPH-stimulated O 2 Ϫ ⅐ production were expressed as nanomoles of O 2 Ϫ ⅐ per minute per milligram of protein by calibration with SOD-inhibitable cytochrome c reduction (57) . Protein was measured using the Bradford method (Bio-Rad; Hercules, CA).
Renal cortical mRNA and protein expression. Kidneys were harvested from separate groups of rats (n ϭ 6 per group) after perfusion to wash out blood. The cortex was separated and processed as described (28) . The mRNA was extracted and assayed for p22 phox , EC-SOD, and 18s by real-time PCR using methods described (7). The protein was extracted and assayed for p22
phox by Western blot analysis using a validated antibody (7) . Validated antibodies to EC-SOD are not available commercially.
Statistical methods. Values are reported as means Ϯ SE. An analysis of variance (ANOVA) assessed the separate and interactive effects of infusions of ANG II and Tempol. Where appropriate, a post hoc Dunnett's t-test was applied to assess differences between groups. Statistical significance was assumed at P Ͻ 0.05. Table 1 shows that there were no significant differences in body weight or hematocrit between the groups. Tempol prevented the reduction in 24-h urine volume with ANG II. Rats infused with ANG II had an increase in MAP and renal vascular resistance (RVR) that were prevented by coinfusion of Tempol (Fig. 1) . ANG II reduced the GFR, RPF, and RBF. Surprisingly, Tempol alone also reduced these values and, when infused with ANG II, did not restore the GFR (Table 1) . Parameters of renal oxygen usage and demand obtained under anesthesia are shown in Table 2 . There were no differences in arterial O 2 content. ANG II increased renal Q O 2 despite a reduced RBF because of an enhanced arteriovenous difference for O 2 across the kidney. Tempol infused alone did not change Q O 2 but prevented the increase with ANG II. T Na was reduced by ANG II, Tempol, and ANG II ϩ Tempol because of reductions in GFR. Therefore, the T Na :Q O 2 was reduced sharply by ANG II (Fig. 5 ). This ratio was normalized by coinfusion of Tempol, which had no significant effects when given alone.
RESULTS
Values of PO 2 measured in arterial blood and in the lumen of proximal tubules (PT), distal tubules (DT), and the interstitium of the OC or IC are shown in Table 3 and Fig. 6 . There were no changes in arterial PO 2 . However, ANG II reduced significantly the PO 2 at all four sites in the kidney cortex. These effects were prevented by coadministration of Tempol, which actually increased the PO 2 above values in vehicle-infused rats in the PT and IC.
DISCUSSION
Previous studies in mice (26) and rats (7, 19, 35, 45, 46, 48) have shown that prolonged low-dose infusions of ANG II cause oxidative stress. The main findings of this study are that a slow pressor infusion of ANG II increases renal cortical NADPH oxidase activity, accompanied by increased expression of p22 phox and decreased expression of EC-SOD. Whereas this confirms prior findings that AT 1 receptors reduce EC-SOD expression in rats (7) and humans (23) , opposite effects are reported in mice (17) . ANG II causes hypertension, renal vasoconstriction, and inefficient utilization of renal O 2 for tubular Na ϩ transport associated with renal cortical hypoxia. All of these actions are prevented by coperfusion with a SOD mimetic.
A limitation of these studies is that all the functional measurements were made under anesthesia, which may modify the response to ANG II. Nevertheless, we reported similar changes in blood pressure of mice undergoing an ANG II slow pressor response whether measured when conscious or anesthetized (26) . A second limitation is that the effects of ANG II have not been dissociated from secondary consequences of hypertension. Nevertheless, we reported that whereas an angiotensin receptor blocker reversed defective renal oxygenation in the SHR, equiantihypertensive treatment in a regimen that did not perturb angiotensin action was in effective (61).
Harrison and colleagues (35, 48) established that infusion of ANG II, but not equipressor infusions of norepinephrine, increases the expression of p22 phox and generates O 2 Ϫ ⅐ in blood vessel walls. We confirm the findings of Juncos et al. (45) in the rat and Kawada et al. (26) in the mouse that coinfusion of the permeant radical nitroxide Tempol prevents ANG II-induced hypertension and renal vasoconstriction. An unexpected finding was that Tempol given alone reduced the GFR and the RBF. Tempol moderates or reverses the hypertension and oxidative stress in several other models of hypertension, including the SHR (51, 53) , the deoxycorticosterone acetate-salt (DOCA-salt) rat (5) , and the 2K,1C Goldblatt model of renovascular hypertension (62) .
Tempol (25) , hyperoxia (42) , or radiation (20) .
ANG II-induced renal cortical hypoxia was accompanied by inefficient utilization of O 2 for tubular sodium transport. This can be ascribed to oxidative stress because it was prevented by coinfusion of Tempol. As in previous studies in the SHR (60) and the postclip kidney in the 2K,1C model (62) , changes in T Na :Q O 2 were predictive of the associated changes in PO 2 measured directly in the renal cortex.
Other studies have linked inefficient utilization of O 2 and accompanying tissue hypoxia to oxidative stress. Adler et al. (1) showed that the hearts of aging Fischer rats have oxidative stress due to activation of NADPH oxidase and reduced control of myocardial O 2 consumption by NO that can be corrected by Tempol. Li et al. (37) demonstrated that mitochondrial SOD knockout mice have diminished defense against local oxidative stress thereby depleting bioactive NO that normally restrains mitochondrial O 2 usage.
Blockade of the AT 1 receptors is the SHR reverses oxidative stress in the kidney and restores a normal blunting of the tubuloglomerular feedback (TGF) response by endogenous NO (63) . This suggests that AT 1 receptor activation causes oxidative stress in the renal tubules and interstitium of the cortex that curtails NO bioactivity. Inhibition of NOS in the dog sharply reduces the efficiency with which O 2 is used for tubular Na ϩ transport (36) . Thus ANG II-induced oxidative stress might reduce T Na :Q O 2 by limiting NO bioactivity in the kidney. Indeed, whereas a short-term infusion of ANG II increases renal NO generation (56) and the dependence of RBF on NO, these effects are lost during prolonged ANG II infusions (12) . Moreover, the blunting of afferent arteriolar vasoconstriction by NO generated in the afferent arteriole (58, 59) or the macula densa (24) are diminished by prolonged ANG II infusion.
Erythropoietin is secreted in response to a fall in renal cortical PO 2 . Therefore, our finding that ANG II infusions reduce renal cortical PO 2 may underlie the observations that ANG II infusion normally enhances erythropoietin (16) . Moreover, angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor blockers (ARBs) can reverse erythrocytosis in renal transplant recipients and increase erythropoietin requirements in patients with kidney disease (41) . These effects may be secondary to a decrease in renal cortical PO 2 , induced by ANG II, or an increase in PO 2 induced by ACEI or ARBs. However, the hematocrit was not change by ANG II infusion in the present study. Although, the hematocrit was not changed significantly by ANG II in the present study, it was increased by a higher rate of ANG II infusion in a prior study in mice (26) .
Many genes implicated in adverse pathophysiological changes in blood vessels and the kidney during sustained hypertension are activated by the hypoxia-inducible factor (HIF). These include erythropoietin, endothelin-1, vascular endothelial growth factor, tumor necrosis factor-␣, transforming growth factor-␤, and collagen-1 (49, 55) . Therefore, ANG II-induced oxidative stress sufficient to reduce renal PO 2 may provide a global mechanism for activation of a number of pathophysiologic processes that together underlie the adverse events that accompany hypertension and prolonged ANG II excess in the kidney and blood vessels.
An interesting finding was that prolonged administration of Tempol reversed both the increased expression of p22 phox and the decreased expression of EC-SOD in the kidney cortex. Indeed, p22 phox protein expression during ANG II plus Tempol was reduced below basal values. This may explain why Tempol normalizes NADPH oxidase activity in the kidney cortex of ANG II infused rats and reverses oxidative stress in many models of ANG II-induced hypertension (51, 53, 62) .
Perspective. There are two potentially important implications of this study. First, the finding that Tempol corrects the enhanced NADPH oxidase activity, the enhanced expression of p22 phox , and the suppressed expression of EC-SOD in ANG II-induced hypertension provides an insight into the self-sustaining nature of oxidative stress whereby an initial increase in ROS engages a tissue response that can further enhance ROS generation and impair ROS metabolism. A similar response is reported in the stroke-prone SHR where chronic administration of Tempol (47) or vitamins E and C (10) reverse the activated vascular NADPH oxidase and suppressed SOD. Similarly, an anti-oxidant regimen reverses the enhanced expression of p47 phox and p67 phox and nuclear factor-B in the kidneys of pigs with renovascular hypertension or hypocholesterolemia (8, 9) . This extends the "kindling of the fire" hypothesis for the generation of oxidative stress in blood vessels advanced by Harrison and collegues (22, 34) . Second, the findings suggest how oxidative stress during ANG II infusion or hypertension (27) may be held in check by tissue hypoxia. A reduction in PO 2 enhances NO bioactivity (50) and reduces O 2 .-generation (44) . Therefore, hypoxia may provide the kidney with a means to escape from the vicious cycle whereby oxidative stress causes hypertension and worsens oxidative stress because the accompanying fall in PO 2 should limit ongoing O 2 .-generation. However, this postulated benefit would carry with it the threat of activation of hypoxia-dependent genes, many of which have been associated with progressive kidney disease (14, 21) .
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